Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer. (Q53223636)
Jump to navigation
Jump to search
scientific article published in September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer. |
scientific article published in September 2006 |
Statements
Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer. (English)
1 reference
Michael Kolodziej
1 reference
Marcus A Neubauer
1 reference
Steven R Rousey
1 reference
Robert E Pluenneke
1 reference
George Perrine
1 reference
Stephanie Mull
1 reference
Kristi A Boehm
1 reference
Des Ilegbodu
1 reference
Lina Asmar
1 reference
1 September 2006
1 reference
5
1 reference
155-161
1 reference
2
1 reference
Identifiers
1 reference